Biotronik SE & Co. KG: Peripheral Arterial Disease trials

The registry lists 15 Peripheral Arterial Disease studies with Biotronik SE & Co. KG as lead sponsor. 1 are open to participants now and 1 have results posted.

Phase 2 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First)RecruitingNCT06758921
• Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar StentsCompletedNCT01319812Phase 2Results posted
• BRight Pharmacokinetic StudyCompletedNCT06065345Not applicable
• Evaluation of Standard of Care Practices, Procedural Outcomes and In-hospital Complications of Peripheral Endovascular ProceduresCompletedNCT05831319
• BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac LesionsActive, not recruitingNCT04830228
• BRight DCB First-in-Human StudyCompletedNCT04525794Not applicable
• BIO REsponse Adapted Combination Therapy Pilot StudyStatus unknownNCT03547986Not applicable
• BIOLUX P-III BENELUX All-Comers RegistryCompletedNCT03052309
• BIOLUX P-III SPAIN All-Comers RegistryCompletedNCT03052296
• BIOTRONIK 4French for AMBulatory Peripheral InterventionCompletedNCT03044002
• BIOLUX P-IV CHINA ( BIOTRONIK )CompletedNCT02912715Not applicable
• BIOLUX P-III All-Comers Passeo-18 Lux RegistryCompletedNCT02276313
• BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal ArteriesCompletedNCT01867736Not applicable
• Study to Determine the Performance of the Astron and Pulsar-18 Stents in EuropeStatus unknownNCT01661231Not applicable
• BIOLUX P-I First in Man StudyCompletedNCT01221610Not applicable